U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Size

• The U.K. and Republic of Ireland automated external defibrillator (AED) market size was valued at USD 33.55 billion in 2024 and is expected to reach USD 79.02 billion by 2032, at a CAGR of 11.30% during the forecast period
• The market growth is largely fuelled by the rising incidence of sudden cardiac arrests, expansion of public access defibrillation programs, and growing awareness regarding life-saving emergency devices
• The growing participation of private organizations and non-profits in providing AED training and donations to schools, workplaces, and recreational centers is further boosting the market size

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Analysis

• Increasing government initiatives and funding for installation of AEDs in public spaces such as airports, schools, railway stations, and sports venues are contributing significantly to market expansion across the region
• The presence of strong regulatory support from health authorities and favorable guidelines for AED usage is accelerating product adoption in both urban and rural areas
• The automated external defibrillator (AED) devices segment dominated the market with the largest revenue share of 68.5% in 2024, driven by widespread implementation of public access defibrillation (PAD) programs across both countries. The growing number of AED installations in transport hubs, sports venues, and educational institutions has significantly boosted demand for reliable, standalone AED devices. The strong emphasis by government health agencies and non-profit organizations on early intervention in cardiac emergencies continues to sustain high procurement volumes for these devices.

Report Scope and U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Segmentation         

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Trends

Rising Integration of AEDs in Public and Private Infrastructure

•  The increasing installation of automated external defibrillators (AEDs) across public spaces, transportation hubs, workplaces, and educational institutions is significantly enhancing accessibility and emergency preparedness in the U.K. and Republic of Ireland. This widespread deployment is driven by growing public health awareness and legislative mandates that encourage or require AED availability in high-footfall areas
•  Technological advancements have led to the development of connected AEDs capable of transmitting real-time usage and maintenance data to central systems. These smart AEDs support better asset management, reduce device downtime, and enhance user confidence by ensuring readiness at all times. Integration with emergency response systems also allows faster coordination in critical situations
•  Public-private partnerships and government grants are facilitating AED adoption in rural and underserved communities. Nonprofit organizations, local councils, and healthcare providers are actively collaborating to train bystanders and equip public places with life-saving devices, resulting in more favorable outcomes during cardiac emergencies
•  For instance, in 2024, the British Heart Foundation collaborated with several local councils across England and Northern Ireland to install over 1,000 new AEDs in community centers, sports grounds, and libraries. The initiative included free CPR training workshops and awareness campaigns, leading to increased survival rates in out-of-hospital cardiac arrests
•  Despite progress, the full potential of AEDs will only be realized through ongoing investments in public education, maintenance programs, and rural outreach. Market stakeholders must continue to innovate and ensure the sustainability of widespread AED coverage across all population segments

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Dynamics

Driver

Increasing Incidence of Sudden Cardiac Arrest and Strong Government Initiatives

•  Sudden cardiac arrest (SCA) remains one of the leading causes of death in the U.K. and Ireland, pushing policymakers and healthcare bodies to adopt aggressive AED deployment strategies. National campaigns highlighting the importance of early defibrillation and CPR have strengthened public support for expanding access to AEDs
•  Emergency services and first responder networks are increasingly equipped with portable defibrillators, improving survival rates during the critical first minutes following a cardiac event. The emphasis on rapid response has also fueled demand for compact, user-friendly AEDs suitable for public and private use
•  Regulatory frameworks have played a vital role in expanding the market. Several city councils have mandated AED installation in newly built commercial buildings, while workplace health and safety regulations now consider AED access as part of occupational risk management
•  For example, in 2023, the Scottish Government launched the “Every Life Matters” program, which included funding for AED units across remote highland communities and tourism hotspots, paired with basic life support training for local residents
•  These efforts are significantly increasing public AED availability and awareness, but maintaining momentum will require consistent policy support, funding mechanisms, and awareness-building activities

Restraint/Challenge

Maintenance Burden and Lack of User Confidence in Emergency Scenarios

•  One of the key challenges limiting AED adoption is the burden of regular device maintenance, which includes battery checks, electrode replacement, and device software updates. Organizations often lack the resources or expertise to manage this effectively, leading to concerns about device readiness during emergencies
•  Despite simplified instructions, bystander hesitation due to fear of causing harm or legal liability remains prevalent. Limited training opportunities and lack of confidence in using AEDs often prevent prompt intervention during cardiac arrests, particularly in non-clinical environments
•  Cost also remains a limiting factor for smaller organizations and rural communities, where budget constraints delay AED procurement and training. While grants and charitable support exist, gaps in distribution persist
•  For instance, a 2024 survey by the Resuscitation Council U.K. revealed that nearly 40% of community AED units had expired pads or inactive batteries, reducing their effectiveness during critical emergencies
•  Bridging these gaps requires a more robust maintenance infrastructure, continuous public education, and the integration of AED deployment into broader health and safety planning. Long-term success will depend on ensuring operational reliability and boosting public confidence in using AEDs without hesitation

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Scope

The market is segmented on the basis of product type, application, end user, and distribution channel.

• By Product Type

On the basis of product type, the U.K. and Republic of Ireland AED market is segmented into automated external defibrillator (AED) devices and AED accessories. The automated external defibrillator (AED) devices segment dominated the market with the largest revenue share of 68.5% in 2024, driven by widespread implementation of public access defibrillation (PAD) programs across both countries. The growing number of AED installations in transport hubs, sports venues, and educational institutions has significantly boosted demand for reliable, standalone AED devices. The strong emphasis by government health agencies and non-profit organizations on early intervention in cardiac emergencies continues to sustain high procurement volumes for these devices.

The AED accessories segment is expected to witness the fastest growth from 2025 to 2032, supported by the recurring need for replacement pads, batteries, wall cabinets, signage, and carrying cases. As AED deployment increases, the demand for accessory upgrades and maintenance essentials also grows, especially among organizations aiming to maintain compliance with safety standards and readiness protocols.

• By Application

On the basis of application, the U.K. and Republic of Ireland AED market is segmented into ventricular fibrillation, pulseless ventricular tachycardia, and others. The ventricular fibrillation segment led the market in 2024 with the highest revenue share, largely attributed to its status as the most common initial rhythm in sudden cardiac arrest (SCA) cases. The rapid-response advantage of AEDs in treating ventricular fibrillation has made their deployment crucial in both community and clinical settings.

The pulseless ventricular tachycardia segment is expected to witness the fastest growth from 2025 to 2032, owing to the increased awareness of cardiac arrhythmias and the incorporation of AEDs in first responder kits. AEDs remain an effective first-line intervention for pulseless VT, reinforcing their role in emergency cardiac care.

• By End User

On the basis of end user, the market is segmented into pre-hospital care and emergency medical service (EMS) providers, hospitals, ambulatory surgical centers (ASC), cardiac centers, public access, military and defense, home care settings, ambulatory care centers, specialty clinics, and others. The public access segment accounted for the largest revenue share in 2024, driven by the ongoing expansion of community defibrillation programs in the U.K. and Ireland. Government-backed initiatives and widespread public training on AED use have contributed to increasing installations in offices, malls, train stations, and schools.

The home care settings segment is expected to witness the fastest growth from 2025 to 2032, supported by rising demand for personal AED units among high-risk cardiac patients and the elderly population. Growing emphasis on self-care and remote patient monitoring is further boosting adoption of compact, user-friendly AEDs for at-home use.

• By Distribution Channel

On the basis of distribution channel, the U.K. and Republic of Ireland AED market is segmented into direct tender, online sales, retail sales, and others. The direct tender segment held the highest revenue share in 2024, largely driven by large-scale procurement by healthcare institutions, EMS agencies, and government health departments. The centralized purchasing model enables bulk acquisition at negotiated prices, contributing to cost efficiency for public health systems.

The online sales segment is expected to witness the fastest growth from 2025 to 2032, fuelled by the rise of e-commerce platforms and direct manufacturer-to-consumer sales. The convenience of online product comparison, ease of ordering, and expanding digital presence of medical equipment providers are key contributors to this trend.

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Share

The U.K. and Republic of Ireland Automated External Defibrillator (AED) industry is primarily led by well-established companies, including:

•  HeartSine Technologies, Ltd. (U.K.)
•  Rapid Response Revival Ltd. (U.K.)
•  Aero Healthcare Ltd. (U.K.)
•  Defib Machines Ltd. (U.K.)
•  Imperative Training Ltd. (U.K.
•  WEL Medical Ltd. (U.K.)
•  Defib Store Ltd. (U.K.)
•  St John Ambulance (U.K.)
•  The Defib Centre Ltd. (U.K.)
•  Defibshop Ltd. (U.K.)
•  Martek Lifecare Ltd. (U.K.)
•  First Aid Warehouse Ltd. (U.K.)
•  Pulse Medical Ltd. (U.K.)
•  The Defib Warehouse (U.K.)
•  Medguard Professional Healthcare Supplies (Republic of Ireland)

Latest Developments in U.K. and Republic of Ireland Automated External Defibrillator (AED) Market

• In November 2023, Metrax GmbH participated in MEDICA 2023, a leading global medical trade fair held in Düsseldorf. The event, known for drawing over 5,000 exhibitors and more than 120,000 visitors, provided a strong platform for showcasing innovations in medical technology, healthcare, and pharmaceuticals. This exposure is expected to enhance Metrax’s international visibility and strengthen its position in the Automated External Defibrillator (AED) market
• In November 2022, Progetti srl showcased its advanced AEDs—Rescue Life 9 and RESCUE SAM 4.0D—at MEDICA 2022. Rescue Life 9 featured a durable TFT LCD display and long battery life, while RESCUE SAM 4.0D offered a rapid analysis system for efficient defibrillation. These innovations are designed to attract global interest, improve emergency response efficiency, and support market expansion
• In February 2022, Koninklijke Philips N.V. was named a Top 100 Global Innovator for the eighth consecutive year. This recognition reinforces Philips' strong commitment to research and development, inspiring future innovations in life-saving technologies, including AEDs, and strengthening its reputation and competitive edge in the U.K. and Republic of Ireland market
• In March 2021, ZOLL Medical Corporation, a subsidiary of Asahi Kasei Corporation, received a USD 10 million donation to its nonprofit foundation. With USD 2.5 million already allocated to 69 young investigators across 14 countries, this initiative supports research in resuscitation and acute care. It is expected to drive innovation and contribute to the development of next-generation AED solutions
• In November 2020, HEARTHERO secured CE Mark approval for its AED device "Elliot," designed with a focus on affordability, portability, and ease of use. This milestone allows the company to enter the European market with a competitive edge, promoting broader access to life-saving defibrillation technology and potentially reducing cases of Sudden Cardiac Death

SKU-70423